Showing results (351-360 of 1,822) with videos related to

Sort By:
Pageof 183
Signal Transduction and Targeted Therapy|April 2, 2025
A donor PD-1+CD8+ TSCM-like regulatory subset mobilized by G-CSF alleviates recipient acute graft-versus-host-diseaseDan Liu, Xue Wang, Yuheng Han, et al.
Signal Transduction and Targeted Therapy|April 13, 2025
Oncogenic gene fusions in cancer: from biology to therapyStephen V Liu, Misako Nagasaka, Judith Atz, et al.
Signal Transduction and Targeted Therapy|February 25, 2026
Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosisBhavika B Katariya, Shashipavan Chillappagari, Lisa Arnold, et al.
Signal Transduction and Targeted Therapy|February 27, 2026
Efficacy and safety of bofanglutide, a GLP-1 receptor agonist, in Chinese adults with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trialLinong Ji, Leili Gao, Junhang Tian, et al.
Signal Transduction and Targeted Therapy|March 2, 2026
Thromboxane receptor activation in dendritic cells mitigates sepsis by suppressing S100a8/a9-mediated neutrophil recruitmentRonglu Du, Ting Pan, Yuhan Wang, et al.
Signal Transduction and Targeted Therapy|March 10, 2026
Nature-inspired confined cascade enzyme nanoreactors for targeted atherosclerosis therapyYuehuang Wu, Hongping Xia, He Ding, et al.
Signal Transduction and Targeted Therapy|February 8, 2024
Major depressive disorder: hypothesis, mechanism, prevention and treatmentLulu Cui, Shu Li, Siman Wang, et al.
Signal Transduction and Targeted Therapy|March 26, 2024
First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 studyXiaofeng Chen, Hao Xu, Xiaobing Chen, et al.
Signal Transduction and Targeted Therapy|February 15, 2024
Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseasesJian Sheng Loh, Wen Qi Mak, Li Kar Stella Tan, et al.
Signal Transduction and Targeted Therapy|February 11, 2024
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinomaGian Luca Rampioni Vinciguerra, Marina Capece, Luca Reggiani Bonetti, et al.
Pageof 183